Arkolith/Insider Trading/EVLO/Form 4

Flagship Ventures Fund IV General Partner LLC

10% OwnerEvelo Biosciences, Inc. (EVLO) · full profile →Form 4 · filed Jul 13, 2023
Net Buying
Open-Market Buys
$12.5M
Open-Market Sells
$0
Net Open-Market Flow
$12.5M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 11, 2023Buy(P)1.1M$2.31$2.5M1.5M
Jul 11, 2023Buy(P)3.2M$2.31$7.5M3.9M
Jul 11, 2023Buy(P)1.1M$2.31$2.5M1.5M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-032871) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML